Oral Session 2-8D DLBCL: Clinical practice

[OS2-8D-3] Clinical features of second primary malignancy in patients with diffuse large B cell lymphoma

Kazuna Tanba¹, Yoshiaki Chinen^1,8, Hitoji Uchiyama^2,8, Nobuhiko Uoshima^3,8, Kazuho Shimura^4,8, Shin-Ichi Fuchida^5,8, Miki Kiyota^6,8, Mitsushige Nakao^7,8, Tsutomu Kobayashi^1,8, Shigeo Horiike^1,8, Katsuya Wada^6,8, Chihiro Shimazaki^5,8, Hiroto Kaneko^4,8, Yutaka Kobayashi^3,8, Masafumi Taniwaki⁸, Junya Kuroda^1,8 (1.Division of hematology and oncology, Kyoto prefectual university of medicine, 2.Department of Hematology, Japan Red Cross Kyoto Daiichi Hospital, 3.Department of Hematology, Japan Red Cross Kyoto Daini Hospital, 4.Department of Hematology, Aiseikai Yamashina Hospital, 5.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, 6.Department of Hematology, Matsushita Memorial Hospital, 7.Department of Internal Medicine, Otsu Municipal Hospital, 8.Kyoto Clinical Hematology Study Group)